Mereo BioPharma Group - Financial Ratios for Analysis 2018-2024 | MREO

Fifteen years of historical annual and quarterly financial ratios and margins for Mereo BioPharma Group - (MREO).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
202320222021202020192018
6.723.097.923.471.022.13
0.08-0.1413.780.120.31
0.090.260.16-1.080.510.66
74.26-50.89---
-284.16--57.42---
-284.16--57.42---
-278.50--55.65---
-299.98-39.06---
-294.66-34.90---
0.15-0.29---
------
--16.37---
--22.30---
-58.31-82.1414.461,093-86.56-97.74
-59.59-82.1420.06351830-23,117.10
-44.31-54.5410.07-259.95-40.31-47.61
-53.64-82.1412.43-13,973.35-76.36-67.55
0.360.411.03-0.282.623.07
-0.16-0.40-0.06-0.54-3.28-2.17
-0.16-0.40-0.07-0.54-3.28-2.17

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-03-312023-12-312023-03-31
4.86--
---
0.11--
---
---
---
---
---
---
---
---
---
---
-20.90--
-21.38--
-16.00--
-20.90--
0.31--
-0.060.00-0.07
-0.06--0.07